HK1021801A1 - Composition for gene transfer to the central nervous system - Google Patents
Composition for gene transfer to the central nervous systemInfo
- Publication number
- HK1021801A1 HK1021801A1 HK99106210A HK99106210A HK1021801A1 HK 1021801 A1 HK1021801 A1 HK 1021801A1 HK 99106210 A HK99106210 A HK 99106210A HK 99106210 A HK99106210 A HK 99106210A HK 1021801 A1 HK1021801 A1 HK 1021801A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cells
- composition
- nervous system
- central nervous
- gene transfer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/629,308 US6210664B1 (en) | 1996-04-08 | 1996-04-08 | Method for gene transfer to the central nervous system |
PCT/US1997/005746 WO1997037684A1 (en) | 1996-04-08 | 1997-04-07 | Method for gene transfer to the central nervous system |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1021801A1 true HK1021801A1 (en) | 2000-07-07 |
Family
ID=24522456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK99106210A HK1021801A1 (en) | 1996-04-08 | 1999-12-30 | Composition for gene transfer to the central nervous system |
Country Status (14)
Country | Link |
---|---|
US (2) | US6210664B1 (xx) |
EP (1) | EP0927043B8 (xx) |
JP (2) | JP2000508641A (xx) |
AT (1) | ATE347903T1 (xx) |
AU (1) | AU724537C (xx) |
CA (1) | CA2251232C (xx) |
DE (1) | DE69737101T2 (xx) |
DK (1) | DK0927043T3 (xx) |
ES (1) | ES2277356T3 (xx) |
HK (1) | HK1021801A1 (xx) |
PT (1) | PT927043E (xx) |
TW (1) | TWI222870B (xx) |
WO (1) | WO1997037684A1 (xx) |
ZA (1) | ZA972971B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6210664B1 (en) * | 1996-04-08 | 2001-04-03 | New York University Medical Center | Method for gene transfer to the central nervous system |
CA2647246C (en) * | 2006-03-30 | 2015-06-23 | Research Foundation Of City University Of New York | Stimulation of neuron regeneration by secretory leukocyte protease inhibitor |
EP3801378A4 (en) | 2018-05-24 | 2022-02-23 | Celanese EVA Performance Polymers LLC | IMPLANTABLE DEVICE FOR THE DELAYED RELEASE OF A MACROMOLECULAR DRUG COMPOUND |
CA3087238A1 (en) | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3852823T2 (de) * | 1987-09-11 | 1995-05-24 | Whitehead Biomedical Inst | Transduktionsveränderte fibroblasten und ihre anwendung. |
US5650148A (en) * | 1988-12-15 | 1997-07-22 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
EP0554352B1 (en) * | 1990-10-19 | 2003-03-05 | New York University | A method for transplanting cells into the brain and therapeutic uses therefor |
US5618531A (en) * | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
US5529774A (en) | 1991-08-13 | 1996-06-25 | The Regents Of The University Of California | In vivo transfer of the HSV-TK gene implanted retroviral producer cells |
WO1993014790A1 (en) * | 1992-01-23 | 1993-08-05 | New York University | A method for transplanting cells into the brain and therapeutic uses therefor |
DE69431295T2 (de) * | 1993-04-21 | 2003-05-15 | Pasteur Institut | Biokompatibles implantat zur in vivo expression und sekretion von therapeutischer verbindung |
DK0802800T3 (da) * | 1993-08-12 | 2002-10-07 | Neurotech Sa | Biokompatible immunoisolatoriske kapsler indeholdende genetisk ændrede celler for levering af biologisk aktive molekyler |
US5688773A (en) * | 1994-08-17 | 1997-11-18 | The General Hospital Corporation | Method of selectively destroying neoplastic cells |
US6210664B1 (en) * | 1996-04-08 | 2001-04-03 | New York University Medical Center | Method for gene transfer to the central nervous system |
-
1996
- 1996-04-08 US US08/629,308 patent/US6210664B1/en not_active Expired - Fee Related
-
1997
- 1997-04-07 JP JP9536418A patent/JP2000508641A/ja not_active Withdrawn
- 1997-04-07 ES ES97920192T patent/ES2277356T3/es not_active Expired - Lifetime
- 1997-04-07 WO PCT/US1997/005746 patent/WO1997037684A1/en active IP Right Grant
- 1997-04-07 DE DE69737101T patent/DE69737101T2/de not_active Expired - Fee Related
- 1997-04-07 AT AT97920192T patent/ATE347903T1/de not_active IP Right Cessation
- 1997-04-07 EP EP97920192A patent/EP0927043B8/en not_active Expired - Lifetime
- 1997-04-07 CA CA002251232A patent/CA2251232C/en not_active Expired - Fee Related
- 1997-04-07 AU AU24449/97A patent/AU724537C/en not_active Ceased
- 1997-04-07 PT PT97920192T patent/PT927043E/pt unknown
- 1997-04-07 DK DK97920192T patent/DK0927043T3/da active
- 1997-04-08 ZA ZA9702971A patent/ZA972971B/xx unknown
- 1997-04-09 TW TW086104516A patent/TWI222870B/zh not_active IP Right Cessation
-
1999
- 1999-12-30 HK HK99106210A patent/HK1021801A1/xx not_active IP Right Cessation
-
2000
- 2000-12-04 US US09/730,328 patent/US6565845B2/en not_active Expired - Fee Related
-
2004
- 2004-08-11 JP JP2004234879A patent/JP2004337176A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20010003585A1 (en) | 2001-06-14 |
WO1997037684A1 (en) | 1997-10-16 |
DE69737101T2 (de) | 2007-05-31 |
US6565845B2 (en) | 2003-05-20 |
EP0927043B8 (en) | 2007-04-18 |
JP2004337176A (ja) | 2004-12-02 |
EP0927043A4 (en) | 2004-09-01 |
PT927043E (pt) | 2007-03-30 |
AU724537C (en) | 2001-07-19 |
EP0927043A1 (en) | 1999-07-07 |
TWI222870B (en) | 2004-11-01 |
CA2251232C (en) | 2005-10-25 |
AU724537B2 (en) | 2000-09-21 |
ES2277356T3 (es) | 2007-07-01 |
DK0927043T3 (da) | 2007-04-10 |
ATE347903T1 (de) | 2007-01-15 |
CA2251232A1 (en) | 1997-10-16 |
US6210664B1 (en) | 2001-04-03 |
DE69737101D1 (de) | 2007-01-25 |
ZA972971B (en) | 1997-11-03 |
AU2444997A (en) | 1997-10-29 |
EP0927043B1 (en) | 2006-12-13 |
JP2000508641A (ja) | 2000-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Devine | Mesenchymal stem cells: will they have a role in the clinic? | |
Kim | Human neural stem cells genetically modified for brain repair in neurological disorders | |
EP1007630A4 (en) | NATURAL KILLER CELL LINES AND METHODS OF USE | |
GR3036216T3 (en) | Liver reserve cells. | |
DE69737949D1 (de) | Isolierung, vermehrung und gezielte differenzierung von zäugetierstammzellen des zentralnervensystems | |
CA2407505A1 (en) | Hepatocyte lineage cells derived from pluripotent stem cells | |
CA2402299A1 (en) | Serum free cultivation of primate embryonic stem cells | |
AU2369595A (en) | In vitro growth of functional islets of langerhans and in vivo uses thereof | |
SE0201328D0 (sv) | Hematopoietic differentiation of human embryonic stem cells | |
IL148008A0 (en) | Conditional immortalisation of cells | |
NZ516236A (en) | Altering life span of a recipient cell by transferring cell cytoplasm from a donor cell for use in gene therapy and cloning | |
DK0728194T3 (da) | In situ modifikation og manipulation af stamceller fra centralnervesystemet. | |
CA2320073A1 (en) | Method of controlling proliferation and differentiation of stem and progenitor cells | |
CN1839202B (zh) | 细胞毒性淋巴细胞的制备方法 | |
McIvor et al. | Transient expression of PU. 1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation | |
HK1021801A1 (en) | Composition for gene transfer to the central nervous system | |
DE60032508D1 (de) | VERFAHREN ZUR VERMEHRUNG VON NATüRLICHEN KILLERZELLEN | |
IL137304A0 (en) | Expanded and genetically modified populations of human hematopoietic stem cells | |
Chan et al. | Enhanced in vivo homing of uncultured and selectively amplified cord blood CD34+ cells by cotransplantation with cord blood-derived unrestricted somatic stem cells | |
ATE228000T1 (de) | Verfahren zur verminderung der strahlentherapie oder der radiomimetischen chemotherapie bei der transplantation von hematopoietischen, pluripotenten zellen | |
EP0808364A4 (en) | HUMAN PANCREAS CELL LINES: DEVELOPMENTS AND APPLICATIONS | |
WO2001028574A3 (en) | Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain | |
Karikusa et al. | The restoration of the functions of serially passaged calf hepatocytes by spheroid formation | |
CA2548157A1 (en) | Cell culture with nm23, cell culture media comprising nm23 and therapeutic use of cells cultured in the presence of nm23. | |
TOMITA et al. | Isozyme patterns of branched-chain amino acid transaminase in cultured morris hepatoma 7316A |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Change of ownership |
Owner name: TITAN PHARMACEUTICALS, INC. Free format text: FORMER OWNER(S): NEW YORK UNIVERSITY MEDICAL CENTER, THERACELL, INC Owner name: NEW YORK UNIVERSITY MEDICAL CENTER Free format text: FORMER OWNER(S): NEW YORK UNIVERSITY MEDICAL CENTER, THERACELL, INC |
|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110407 |